Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Jorgen Drejer Ph.D.

Market Cap

424.49 Million SEK

Sector

Healthcare

Website

https://www.saniona.com

Description

Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark.

Read More

Overview

Value

1

Growth

38

Health

46

Management

60

Analyst Opinion

86

Total

46

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Liked by analysts
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Earnings have declined recently
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • 0
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth
  • Accounting anomalies: Growing revenues without a corresponding growth in cash flows.
  • 0

Market Peers

SANION.ST

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-199.37%

Revenue Growth (5 Year Average)

25.07%

Ratings Consensus

Strong Buy

Share Buybacks

-55.74%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined SEK is lower than current price ( 6.13 SEK)
  • Free-cashflow-yeild of -107.15% is worse than the market average (4.7%)
  • Margin-of-safety of -199.37% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 5 SEK

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-107.15%

PE/Earnings Growth

N/A

Price/Book

3.38x

Growth

Growth Score

38

  • 5 Year Average Revenue growth of 25.07% is higher than the market average (10.97%)
  • Revenue growth has improved this yeara
  • 5 Year Average Earnings growth of 19.86% is higher than the market average (14.48%)
  • Free Cashflow growth has improved this year
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of -24.55% is lower than the market average (12.35%)

Revenue Growth

25.07%

Earnings Growth

19.86%

Cashflow Growth

-24.55%

Health

Health Score

46

  • Has a low level of debt
  • Assets cover liabilities
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • 0
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

4.00

Debt/Equity

0.35x

Current Assets/Liabilities

5.99x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

0.26x

Management

Management Score

60

  • Has issued new shares to finance growth when share price is high
  • Return-on-capital-employed of -77.18% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of -145.79% is lower than the market average (15%)

Average Buybacks/Dilution

-55.74%

Recent Buybacks/Dilution

0.01%

5 Year Price Volitility

27.20%

Return On Assets

-93.38%

Return On Capital Employed

-77.18%

Return On Equity

-145.79%

Return On Free Cashflow

228.77%

Return On Investments

-61361.46%

Analysts

Analyst Opinion

86

  • Ratings consensus is Strong Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Saniona AB (publ)

Currency

SEK

Beta

0.754117

Vol Avg

188577

Ceo

Mr. Jorgen Drejer Ph.D.

Cik

Cusip

Exchange

Stockholm Stock Exchange

Full Time Employees

25

Industry

Biotechnology

Sector

Healthcare

Ipo Date

2014-04-22

Address

Smedeland 26B

City

Glostrup

State

Country

DK

Zip

2600

Phone

45 70 70 52 25

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies